|
Lawrence C. Fritz, Ph.D. joined us as President and Chief Executive Officer and a member of our Board of Directors on November 20, 2006. Previously, he founded Conforma Therapeutics, a privately held biotechnology company, and served as its President and Chief Executive Officer from its inception in 1999 through its acquisition by Biogen Idec in 2006. Dr. Fritz was also a founder and Director of Cabrellis Pharmaceuticals, a specialty pharma cancer company spun-out from Conforma in conjunction with Biogen Idec’s acquisition. Cabrellis was acquired by Pharmion Corporation in November 2006. Prior to Conforma, Dr. Fritz co-founded both Athena Neurosciences Inc., a biotechnology company, now wholly-owned by Elan Corporation, and Idun Pharmaceuticals, Inc., a privately held biotechnology company, subsequently acquired by Pfizer, Inc. He served as Vice President of Research at Athena and as Executive Vice President, Research at Idun. Dr. Fritz holds an A.B. Degree in Biochemical Sciences from Harvard University, a M.Sc. Degree in Physiology from University College London, and a Ph.D. in Biophysics from The Rockefeller University. | 